Dendritic cell lineage, plasticity and cross-regulation.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 11429541)

Published in Nat Immunol on July 01, 2001

Authors

Y J Liu1, H Kanzler, V Soumelis, M Gilliet

Author Affiliations

1: DNAX Research Institute, 901 California Ave., Palo Alto, CA 94304, USA. yliu@dnax.org

Articles citing this

Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest (2002) 4.73

Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med (2002) 3.86

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med (2007) 3.78

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med (2002) 2.96

Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol (2003) 2.93

Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth (2013) 2.70

Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol (2002) 2.46

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med (2002) 2.32

IFNs and STATs in innate immunity to microorganisms. J Clin Invest (2002) 2.04

Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol (2004) 1.72

Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer (2003) 1.65

Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol (2009) 1.55

Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med (2003) 1.54

Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses. J Exp Med (2002) 1.41

Human dendritic cell deficiency: the missing ID? Nat Rev Immunol (2011) 1.32

Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun (2002) 1.31

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut (2005) 1.27

Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood (2007) 1.27

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther (2006) 1.27

Phenotypic characterization of human decidual macrophages. Clin Exp Immunol (2003) 1.24

Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol (2004) 1.23

Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol (2004) 1.17

Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J Exp Med (2002) 1.15

Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun (2002) 1.12

Innate immune cells in liver inflammation. Mediators Inflamm (2012) 1.11

Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am J Pathol (2008) 1.07

IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR). Evid Based Complement Alternat Med (2004) 1.03

Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res (2015) 1.00

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol (2012) 0.98

Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol (2008) 0.98

Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice. Am J Pathol (2010) 0.97

Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc (2010) 0.97

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors. J Cancer (2011) 0.95

T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets. Blood (2011) 0.95

Generation and characterization of chicken bone marrow-derived dendritic cells. Immunology (2009) 0.95

Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol (2007) 0.94

Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. Biochem Biophys Res Commun (2005) 0.93

Dendritic cell-based vaccines: barriers and opportunities. Future Oncol (2012) 0.91

The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells. J Virol (2003) 0.90

An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol (2013) 0.87

Cancer vaccines: on the threshold of success. Expert Opin Emerg Drugs (2008) 0.87

Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy. Cancer J (2011) 0.86

Dendritic cells: potential triggers of autoimmunity and targets for therapy. Ann Rheum Dis (2005) 0.86

Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease. J Histochem Cytochem (2007) 0.85

Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis. Inflamm Bowel Dis (2009) 0.85

Characterization of transglutaminase type II role in dendritic cell differentiation and function. J Leukoc Biol (2010) 0.84

Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci (Landmark Ed) (2009) 0.84

Involvement of Toll-like receptors on Helicobacter pylori-induced immunity. PLoS One (2014) 0.84

Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production. J Immunol (2014) 0.84

Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. Clin Exp Immunol (2007) 0.84

Expanded numbers of circulating myeloid dendritic cells in patent human filarial infection reflect lower CCR1 expression. J Immunol (2010) 0.83

The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response. Int J Mol Sci (2013) 0.83

Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells. Methods Mol Biol (2010) 0.83

Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats. J Clin Immunol (2005) 0.82

Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection. J Biomed Biotechnol (2010) 0.82

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy. Clin Exp Immunol (2012) 0.82

Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication. BMC Cancer (2009) 0.82

Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways. Sensors (Basel) (2009) 0.82

Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. Virology (2011) 0.81

Human metapneumovirus antagonism of innate immune responses. Viruses (2012) 0.81

Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer. Antimicrob Agents Chemother (2008) 0.81

The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology (2007) 0.81

The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity. PLoS One (2012) 0.81

Hepatitis C virus NS4 protein impairs the Th1 polarization of immature dendritic cells. J Viral Hepat (2009) 0.80

Reduced number and function of peripheral dendritic cells in coeliac disease. Clin Exp Immunol (2007) 0.79

Dendritic cell-associated miRNAs are modulated via chromatin remodeling in response to different environments. PLoS One (2014) 0.79

Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection. Clin Diagn Lab Immunol (2005) 0.79

A human dendritic cell subset receptive to the Venezuelan equine encephalitis virus-derived replicon particle constitutively expresses IL-32. J Immunol (2008) 0.79

Phenotype and function of nasal dendritic cells. Mucosal Immunol (2015) 0.78

In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer (Guildf) (2015) 0.78

Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells. Blood (2009) 0.78

The Role of Antigen-presenting Cells in HIV Pathogenesis. Curr Infect Dis Rep (2002) 0.78

Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background. Am J Pathol (2009) 0.78

Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study. Transl Oncol (2015) 0.78

Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS One (2014) 0.77

Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. Immunobiology (2012) 0.77

Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients. Clin Exp Immunol (2007) 0.77

Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro. J Virol (2006) 0.77

The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells. Cancer Immun (2008) 0.77

Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo. Exp Hematol Oncol (2013) 0.76

Shaping immune responses through the activation of dendritic cells' P2 receptors. Purinergic Signal (2006) 0.76

Donor lung derived myeloid and plasmacytoid dendritic cells differentially regulate T cell proliferation and cytokine production. Respir Res (2012) 0.76

Contradictory immune response in post liver transplantation hepatitis B and C. Int J Inflam (2014) 0.76

TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells. Sci Rep (2016) 0.75

Detection and isolation of dendritic cells using Lewis X-functionalized magnetic nanoparticles. Biomacromolecules (2012) 0.75

Do functional subsets of leukocytes arise by divergent or linear differentiation? Immunology (2002) 0.75

Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis. Front Cardiovasc Med (2017) 0.75

Articles by these authors

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48

Reciprocal control of T helper cell and dendritic cell differentiation. Science (1999) 7.28

Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol (2001) 2.85

Somatic hypermutation in normal and transformed human B cells. Immunol Rev (1998) 2.22

Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med (2001) 1.30

T cell activation and polarization by DC1 and DC2. Curr Top Microbiol Immunol (2000) 1.21

Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur J Immunol (1999) 1.20

Evidence for two distinct azurins in Alcaligenes xylosoxidans (NCIMB 11015): potential electron donors to nitrite reductase. Biochemistry (1995) 0.98

Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis. Dermatology (2013) 0.89

Listeria monocytogenes skin infection with cerebritis and haemophagocytosis syndrome in a bone marrow transplant recipient. J Infect (2005) 0.89

Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin's disease as a potential cause for the absence of Ig in the lymphoma cells. Blood (1999) 0.87

Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. Blood (1998) 0.84

Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later. Ann Oncol (1998) 0.84

Immunoglobulin V genes in Reed-Sternberg cells. N Engl J Med (1996) 0.80

Normal and malignant B-cell development with special reference to Hodgkin's disease. Ann Oncol (1997) 0.79

Prurigo nodularis: retrospective study of 13 cases managed with methotrexate. Clin Exp Dermatol (2014) 0.78

Molecular single cell studies of normal and transformed lymphocytes. Cancer Surv (1997) 0.78

Single cell analysis of Hodgkin/Reed-Sternberg cells. Ann Oncol (1996) 0.78

Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion. FEBS Lett (2000) 0.77

[100 years of Dermatology in French-speaking Switzerland]. Rev Med Suisse (2014) 0.75

[From pathogenesis to treatment: a new era for dermatology]. Rev Med Suisse (2011) 0.75

[Vaccination therapy of malignant melanoma]. Ther Umsch (1999) 0.75